Intrinsic Value

GENX latest financial reports are more than 15 years old.
GENX doesn't have a meaningful market cap.
Not Available for GENX

There is not enough data to reliably calculate the intrinsic value for Genex Pharmaceutical Inc.

Do our valuations actually work? See backtest results .

Alternatives to GENX

Fundamental Analysis

What Genex Pharmaceutical Does

Health Care

Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company is headquartered in Tianjin, Tianjin and currently employs 86 full-time employees. The company went IPO on 2006-05-23. The Company’s main business is engaged in producing and distributing Reconstituted Bone Xenograft (RBX). The RBX is a medical device that accelerates bone healing. The firm distributes its medical devices to hospitals as well as other medical device customers that are not hospitals.

Headquarters
China CN
Employees
86
IPO date
May 23, 2006
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Genex Pharmaceutical Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape